Prescription drugs; prohibit licensing boards from prohibiting practitioners from prescribing for off-label use.

HB 1430 would have prohibited Mississippi's medical, nursing, and pharmacy licensing boards from banning healthcare providers (physicians, advanced practice nurses, and pharmacists) from prescribing or filling medications for uses not approved by the FDA (off-label use). Specifically, it would have prevented the State Board of Medical Licensure, Mississippi Board of Nursing, and State Board of Pharmacy from creating rules that restrict such practices, including for semaglutide prescriptions by nurses. The bill required these boards to allow off-label prescribing and filling as long as it was done by licensed practitioners. However, the bill died on the legislative calendar in February 2025 and did not become law.